Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2012 (2012), Article ID 902324, 8 pages
http://dx.doi.org/10.1155/2012/902324
Research Article

Markers of Sleep-Disordered Breathing and Prediabetes in US Adults

Department of Community Medicine, West Virginia University School of Medicine, 1 Medical Center Drive, P.O. Box 9190, Morgantown, WV 26506, USA

Received 23 December 2011; Revised 25 February 2012; Accepted 25 February 2012

Academic Editor: Faustino R. Pérez-López

Copyright © 2012 Omayma Alshaarawy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Lévy, M. R. Bonsignore, and J. Eckel, “Sleep, sleep-disordered breathing and metabolic consequences,” European Respiratory Journal, vol. 34, no. 1, pp. 243–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Young, M. Palta, J. Dempsey, P. E. Peppard, F. J. Nieto, and K. M. Hla, “Burden of sleep apnea: rationale, design, and major findings of the Wisconsin sleep cohort study,” Wisconsin Medical Journal, vol. 108, no. 5, pp. 246–249, 2009. View at Google Scholar · View at Scopus
  3. Centers for Disease Control and Prevention, “National Diabetes Fact Sheet 2011: national estimates and general information on diabetes and prediabetes in the United States,” Department of Health and Human Services. Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2011.
  4. M. Buysschaert and M. Bergman, “Definition of Prediabetes,” Medical Clinics of North America, vol. 95, no. 2, pp. 289–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. American Diabetes Association, “Summary of revisions to the 2011 clinical practice recommendations,” Diabetes Care, vol. 34, p. S3, 2011. View at Google Scholar · View at Scopus
  6. G. A. Nichols, T. A. Hillier, and J. B. Brown, “Progression from newly acquired impaired fasting glusose to type 2 diabetes,” Diabetes Care, vol. 30, no. 2, pp. 228–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. V. A. Fonseca, “Identification and treatment of prediabetes to prevent progression to Type 2 diabetes,” Clinical Cornerstone, vol. 9, no. 2, pp. 51–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. M. Jacobs-van der Bruggen, G. Bos, W. J. Bemelmans, R. T. Hoogenveen, S. M. Vijgen, and C. A. Baan, “Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study,” Diabetes Care, vol. 30, no. 1, pp. 128–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. A. Hsueh, L. Orloski, and K. Wyne, “Prediabetes: the importance of early identification and intervention,” Postgraduate Medicine, vol. 122, no. 4, pp. 129–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Tuomilehto, M. Peltonen, M. Partinen et al., “Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women -the FIN-D2D survey,” Diabetes, Obesity and Metabolism, vol. 10, no. 6, pp. 468–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Valham, B. Stegmayr, M. Eriksson, E. Hägg, E. Lindberg, and K. A. Franklin, “Snoring and witnessed sleep apnea is related to diabetes mellitus in women,” Sleep Medicine, vol. 10, no. 1, pp. 112–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. K. Yaggi, A. B. Araujo, and J. B. McKinlay, “Sleep duration as a risk factor for the development of type 2 diabetes,” Diabetes Care, vol. 29, no. 3, pp. 657–661, 2006. View at Google Scholar · View at Scopus
  13. N. T. Ayas, D. P. White, W. K. Al-Delaimy et al., “A prospective study of self-reported sleep duration and incident diabetes in women,” Diabetes Care, vol. 26, no. 2, pp. 380–384, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Beihl, A. D. Liese, and S. M. Haffner, “Sleep duration as a risk factor for incident Type 2 diabetes in a multiethnic cohort,” Annals of Epidemiology, vol. 19, no. 5, pp. 351–357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Chaput, J. P. Després, C. Bouchard, and A. Tremblay, “Association of sleep duration with type 2 diabetes and impaired glucose tolerance,” Diabetologia, vol. 50, no. 11, pp. 2298–2304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Chaput, J. P. Després, C. Bouchard, A. Astrup, and A. Tremblay, “Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study,” Sleep Medicine, vol. 10, no. 8, pp. 919–924, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. O. M. Buxton and E. Marcelli, “Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States,” Social Science and Medicine, vol. 71, no. 5, pp. 1027–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Gangwisch, S. B. Heymsfield, B. Boden-Albala et al., “Sleep duration as a risk factor for diabetes incidence in a large US sample,” Sleep, vol. 30, no. 12, pp. 1667–1673, 2007. View at Google Scholar · View at Scopus
  19. S. L. Merritt, “Sleep-disordered breathing and the association with cardiovascular risk,” Progress in Cardiovascular Nursing, vol. 19, no. 1, pp. 19–27, 2004. View at Google Scholar · View at Scopus
  20. H. K. Meier-Ewert, P. M. Ridker, N. Rifai et al., “Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk,” Journal of the American College of Cardiology, vol. 43, no. 4, pp. 678–683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Gottlieb, N. M. Punjabi, A. B. Newman et al., “Association of sleep time with diabetes mellitus and impaired glucose tolerance,” Archives of Internal Medicine, vol. 165, no. 8, pp. 863–868, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Rafalson, R. P. Donahue, S. Stranges et al., “Short sleep duration is associated with the development of impaired fasting glucose: the western New York health study,” Annals of Epidemiology, vol. 20, no. 12, pp. 883–889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. National Center for Health Statistics, “The National Health and Nutrition Examination Survey 2005-2006,” Survey Operations Manuals, Brochures, Consent Documents. 2009, http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/current_nhanes_05_06.htm.
  24. National Center for Health Statistics, “The National Health and Nutrition Examination Survey 2007-2008,” Survey Operations Manuals, Brochures, Consent Documents. 2009, http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/current_nhanes_07_08.htm.
  25. K. G. Baron, K. Liu, C. Chan, E. Shahar, R. Hasnain-Wynia, and P. Zee, “Race and ethnic variation in excessive daytime sleepiness: the multi-ethnic study of atherosclerosis,” Behavioral Sleep Medicine, vol. 8, no. 4, pp. 231–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. O'Brien, C. B. Mervis, C. R. Holbrook et al., “Neurobehavioral implications of habitual snoring in children,” Pediatrics, vol. 114, no. 1, pp. 44–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. National Center for Health Statistics, “Laboratory procedures used for NHANES 2005-2006,” 2009, http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/lab05_06.htm.
  28. S. M. Haffner, M. P. Stern, H. P. Hazuda, B. D. Mitchell, and J. K. Patterson, “Cardiovascular risk factors in confirmed prediabetic individuals,” Journal of the American Medical Association, vol. 263, no. 21, pp. 2893–2898, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. L. C. Plantinga, D. C. Crews, J. Coresh et al., “Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 4, pp. 673–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Manber, T. F. Kuo, N. Cataldo, and I. M. Colrain, “The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study,” Sleep, vol. 26, no. 2, pp. 163–168, 2003. View at Google Scholar · View at Scopus
  31. K. Franklin, R. Lundgren, and T. Rabben, “Sleep apnoea syndrome treated with oestradiol and cyclic medroxyprogesterone,” Lancet, vol. 338, no. 8761, pp. 251–252, 1991. View at Google Scholar · View at Scopus
  32. E. Shahar, S. Redline, T. Young et al., “Hormone replacement therapy and sleep-disordered breathing,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 9, pp. 1186–1192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Perez-Chada et al., “Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension,” Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 7, pp. 788–792, 2007. View at Google Scholar
  34. K. A. Franklin, P. A. Holmgren, F. Jönsson, N. Poromaa, H. Stenlund, and E. Svanborg, “Snoring, pregnancy-induced hypertension, and growth retardation of the fetus,” Chest, vol. 117, no. 1, pp. 137–141, 2000. View at Google Scholar · View at Scopus
  35. Y. T. Celen et al., “Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up,” Journal of Clinical Sleep Medicine, vol. 6, no. 3, pp. 244–250, 2010. View at Google Scholar
  36. C. C. Cowie, K. F. Rust, D. D. Byrd-Holt et al., “Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006,” Diabetes Care, vol. 33, no. 3, pp. 562–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. CDC, Perceived Insufficient Rest or Sleep among Adults, CDC, Atlanta, Ga, USA, 2008.
  38. Y. Wang and M. A. Beydoun, “The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis,” Epidemiologic Reviews, vol. 29, no. 1, pp. 6–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. Mensah, A. H. Mokdad, E. S. Ford, K. J. Greenlund, and J. B. Croft, “State of disparities in cardiovascular health in the United States,” Circulation, vol. 111, no. 10, pp. 1233–1241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Spiegel, R. Leproult, and E. van Cauter, “Impact of sleep debt on metabolic and endocrine function,” Lancet, vol. 354, no. 9188, pp. 1435–1439, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. G. M. Reaven, H. Lithell, and L. Landsberg, “Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system,” New England Journal of Medicine, vol. 334, no. 6, pp. 374–381, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Spiegel, E. Tasali, P. Penev, and E. van Cauter, “Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite,” Annals of Internal Medicine, vol. 141, no. 11, pp. 846–850, 2004. View at Google Scholar · View at Scopus
  43. S. Taheri, L. Lin, D. Austin, T. Young, and E. Mignot, “Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index,” PLoS Medicine, vol. 1, article e62, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Chaput, J. P. Després, C. Bouchard, and A. Tremblay, “Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Québec family study,” Obesity, vol. 15, no. 1, pp. 253–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. R. Irwin, M. Wang, C. O. Campomayor, A. Collado-Hidalgo, and S. Cole, “Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation,” Archives of Internal Medicine, vol. 166, no. 16, pp. 1756–1762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. F. B. Hu, J. B. Meigs, T. Y. Li, N. Rifai, and J. E. Manson, “Inflammatory markers and risk of developing Type 2 diabetes in women,” Diabetes, vol. 53, no. 3, pp. 693–700, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, “C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 286, no. 3, pp. 327–334, 2001. View at Google Scholar · View at Scopus
  48. R. R. Grunstein, D. J. Handelsman, S. J. Lawrence, C. Blackwell, I. D. Caterson, and C. E. Sullivan, “Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy,” Journal of Clinical Endocrinology and Metabolism, vol. 68, no. 2, pp. 352–358, 1989. View at Google Scholar · View at Scopus
  49. O. Marrone, L. Riccobono, A. Salvaggio, A. Mirabella, A. Bonanno, and M. R. Bonsignore, “Catecholamines and blood pressure in obstructive sleep apnea syndrome,” Chest, vol. 103, no. 3, pp. 722–727, 1993. View at Google Scholar · View at Scopus
  50. S. Marshall, W. T. Garvey, and R. R. Traxinger, “New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids,” FASEB Journal, vol. 5, no. 15, pp. 3031–3036, 1991. View at Google Scholar · View at Scopus
  51. M. H. Smolensky, R. C. Hermida, R. J. Castriotta, and F. Portaluppi, “Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension,” Sleep Medicine, vol. 8, no. 6, pp. 668–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Rasch, C. Dodt, M. Mölle, and J. Born, “Sleep-stage-specific regulation of plasma catecholamine concentration,” Psychoneuroendocrinology, vol. 32, no. 8-10, pp. 884–891, 2007. View at Publisher · View at Google Scholar · View at Scopus